Evidence map›Paper›PMID 31767784›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases.

Prakash Babu Narasimhan, Tobias Eggert, Yanfang Peipei Zhu, Paola Marcovecchio, Melissa A Meyer, Runpei Wu, Catherine C Hedrick

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 41 citations in OpenAlex.

  1. Rbp-Jκ controls NK cell late maturation and migration via chromatin landscape remodeling.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Transcription factor C/EBPα is required for the development of Ly6CProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential.International journal of molecular sciences · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Programmed cell death ligand 1 expression on monocytes is inversely correlated with tumour response to preoperative chemoradiotherapy for locally advanced rectal cancer.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Prakash Babu NarasimhanDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA 92037.ORCID 0000-0001-7111-7124
Tobias EggertDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA 92037.
Yanfang Peipei ZhuDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA 92037.ORCID 0000-0001-6908-0860
Paola MarcovecchioDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA 92037.
Melissa A MeyerDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA 92037.ORCID 0000-0003-3050-4819
Runpei WuDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA 92037.
Catherine C HedrickDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA 92037 Hedrick@lji.org.
La Jolla Institute for Immunology · US

Funding

Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosisP01HL136275 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Catherine C Hedrick · 2017 to 2026
$25.5M
Rheumatic Diseases Research Training GrantT32AR064194 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GARY S FIRESTEIN, Monica Guma · 2013 to 2026
$3.8M
Transcriptional Control of Monocyte DevelopmentR01HL134236 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI HEDRICK, CATHERINE C · 2016 to 2019
$2.5M
Functions of Nonclassical Monocytes in the VasculatureR01CA202987 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI HEDRICK, CATHERINE C · 2016 to 2020
$2.2M
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid CancersU01CA224766 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI HEDRICK, CATHERINE C, KAPLAN, ROSANDRA · 2018 to 2021
$1.4M
NCI NIH HHS R01 CA202987NCI NIH HHS U01 CA224766NHLBI NIH HHS P01 HL136275NHLBI NIH HHS R01 HL134236NIAMS NIH HHS T32 AR064194
6 · The paper itself

Abstract

The role of nonclassical, patrolling monocytes in lung tumor metastasis and their functional relationships with other immune cells remain poorly defined. Contributing to these gaps in knowledge is a lack of cellular specificity in commonly used approaches for depleting nonclassical monocytes. To circumvent these limitations and study the role of patrolling monocytes in melanoma metastasis to lungs, we generated C57BL/6J mice in which the Nr4a1 superenhancer E2 subdomain is ablated (

Indexed as

AnimalsCell Line, TumorKiller Cells, NaturalLung NeoplasmsMaleMiceMice, Inbred C57BLMice, KnockoutMonocytesNK Cell Lectin-Like Receptor Subfamily CNK Cell Lectin-Like Receptor Subfamily C

Identifiers

PMID31767784
PMCPMC7890694
OpenAlexW2991528977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.